Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASSOCIATE GLOBAL PARTNERS LIMITED Capital/Financing Update 2016

Aug 24, 2016

64401_rns_2016-08-24_7e16f880-c8ce-49f1-b5de-d3f961e52aba.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [341 x 50] intentionally omitted <==

ASX ANNOUNCEMENT

CHAIRMAN’S ADDRESS TO EXTRAORDINARY GENERAL MEETING

SYDNEY, Australia 25 August, 2016:

During the year, the Company continued to focus on reviewing strategic opportunities for the Company, whilst containing costs.

The Company's proposed acquisition of CAM SPV Pty Ltd, referred to as the SPV Acquisition, will, subject to Shareholders approving all of the Resolutions at today's meeting and subject to completion of the Company's public offer capital raising, provide the Company with a strategic opportunity to change the nature of its activities to become a funds management business with an established management team of funds manager, Contango Funds Management Limited.

Subject to all of the Resolutions being passed at today's meeting, the following screen shows the capital structure of the Company following completion of the public offer prospectus capital raising and issues of securities.

==> picture [480 x 271] intentionally omitted <==

The Company lodged its prospectus dated 18 August 2016 with the Australian Securities and Investments Commission on 18 August 2016 (Prospectus). A copy of the Prospectus is available on the Australian Securities Exchange platform. Resolutions 3 and 4 concern the proposed issue of shares under the Prospectus.

==> picture [452 x 16] intentionally omitted <==

Level 10, 167 Macquarie Street Sydney, New South Wales, 2000 Australia Postal Address: PO Box 449 Dee Why NSW 2099 Australia t+61 2 9889 1830 f +61 2 9889 1805 www.tyriandx.com Tyrian Diagnostics Limited ABN 56 080 277 998

2

The next screen shows indicative dates concerning the opening and closing date of the Prospectus offer and expected date for reinstatement of the Company's securities to official quotation on the ASX. These dates are indicative and are subject to the expiry of the exposure period of the Prospectus and the ASX's determination on the reinstatement of the Company's securities.

==> picture [481 x 271] intentionally omitted <==

Once again, on behalf of the Board I would like to thank you for your continued support, which will enable the Board to deliver to you what the Directors believe to be a new direction with potential.

Contact for further information: Tyrian Diagnostics Ltd Roger Amos Chairman Ph: 0411 447 194

==> picture [452 x 16] intentionally omitted <==

Level 10, 167 Macquarie Street Sydney, New South Wales, 2000 Australia Postal Address: PO Box 449 Dee Why NSW 2099 Australia t+61 2 9889 1830 f +61 2 9889 1805 www.tyriandx.com Tyrian Diagnostics Limited ABN 56 080 277 998